Michael Johnson's most recent trade in Zentalis Pharmaceuticals Inc was a trade of 57,100 Common Stock done . Disclosure was reported to the exchange on June 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zentalis Pharma Inc | David Michael Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2026 | 57,100 | 307,521 | - | 0 | Common Stock | |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.27 per share. | 16 Mar 2026 | 65,510 | 4,061,799 | - | 1.3 | 83,198 | Common Stock |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.36 per share. | 16 Mar 2026 | 21,371 | 4,127,309 | - | 1.4 | 29,065 | Common Stock |
| Herbalife Nutrition Ltd | Michael O. Johnson | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2026 | 399,619 | 399,619 | - | - | Stock Appreciation Rights | |
| Herbalife Nutrition Ltd | Michael O. Johnson | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2026 | 399,619 | 399,619 | - | - | Stock Appreciation Rights | |
| Herbalife Nutrition Ltd | Michael O. Johnson | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2026 | 72,689 | 887,415 (0%) | 0% | 0 | Common Stock | |
| Herbalife Nutrition Ltd | Michael O. Johnson | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2026 | 72,689 | 887,415 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Michael Perkins Johnson | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 3,207 | 3,207 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| Idexx Laboratories | Michael Perkins Johnson | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 770 | 770 | - | - | Restricted Stock Unit | |
| Idexx Laboratories | Michael Perkins Johnson | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 218 | 652 | - | - | Restricted Stock Unit | |
| Idexx Laboratories | Michael Perkins Johnson | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 218 | 2,972 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Michael Perkins Johnson | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 179 | 356 | - | - | Restricted Stock Unit | |
| Idexx Laboratories | Michael Perkins Johnson | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 179 | 2,754 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Michael Perkins Johnson | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 629.35 per share. | 12 Feb 2026 | 178 | 2,794 (0%) | 0% | 629.3 | 112,024 | Common Stock |
| Idexx Laboratories | Michael Perkins Johnson | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 176 | 2,575 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Michael Perkins Johnson | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 176 | 176 | - | - | Restricted Stock Unit | |
| Idexx Laboratories | Michael Perkins Johnson | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 162 | 162 | - | - | Incentive Stock Option (right-to-buy) | |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Sep 2025 | 109,329 | 109,329 | - | - | Common Stock Purchase Warrant (right to buy) | |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Sep 2025 | 23,233 | 23,233 | - | - | Pre-Funded Warrant (right to buy) | |
| Herbalife Nutrition Ltd | Michael O. Johnson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.78 per share. | 29 Aug 2025 | 125,849 | 814,726 (0%) | 0% | 9.8 | 1,230,803 | Common Stock |
| Zentalis Pharma Inc | David Michael Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 57,603 | 250,421 | - | 0 | Common Stock | |
| Idexx Laboratories | Michael Perkins Johnson | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2025 | 3,382 | 0 | - | - | Restricted Stock Unit | |
| Idexx Laboratories | Michael Perkins Johnson | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2025 | 3,382 | 3,864 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Michael Perkins Johnson | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 513.36 per share. | 01 Jun 2025 | 1,499 | 2,365 (0%) | 0% | 513.4 | 769,527 | Common Stock |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2025 | 50,000 | 0 | - | - | Restricted Stock Units | |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 50,000 | 50,000 | - | - | Restricted Stock Units | |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2025 | 50,000 | 106,311 | - | - | Common Stock | |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Apr 2025 | 17,057 | 4,204,991 | - | - | Common Stock | |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Apr 2025 | 17,057 | 0 | - | - | Restricted Stock Unit | |
| Herbalife Nutrition Ltd | Michael O. Johnson | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 442,477 | 442,477 | - | - | Stock Appreciation Rights | |
| Herbalife Nutrition Ltd | Michael O. Johnson | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.62 per share. | 16 Feb 2025 | 125,600 | 940,575 (0%) | 0% | 5.6 | 705,872 | Common Stock |
| Idexx Laboratories | Michael Perkins Johnson | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 3,657 | 3,657 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| Idexx Laboratories | Michael Perkins Johnson | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 870 | 870 | - | - | Restricted Stock Unit | |
| Idexx Laboratories | Michael Perkins Johnson | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 217 | 217 | - | - | Incentive Stock Option (right-to-buy) | |
| Idexx Laboratories | Michael Perkins Johnson | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 179 | 535 | - | - | Restricted Stock Unit | |
| Idexx Laboratories | Michael Perkins Johnson | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 179 | 585 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Michael Perkins Johnson | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 176 | 406 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Michael Perkins Johnson | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 176 | 352 | - | - | Restricted Stock Unit | |
| Idexx Laboratories | Michael Perkins Johnson | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 444.53 per share. | 13 Feb 2025 | 118 | 467 (0%) | 0% | 444.5 | 52,455 | Common Stock |
| Herbalife Nutrition Ltd | Johnson O. Michael | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.48 per share. | 22 Dec 2024 | 87,682 | 1,066,175 (0%) | 0% | 6.5 | 568,179 | Common Stock |
| Zentalis Pharma Inc | David Michael Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 48,429 | 192,818 | - | 0 | Common Stock | |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.98 per share. | 12 Jun 2024 | 134,623 | 4,187,934 | - | 3.0 | 401,500 | Common Stock |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.32 per share. | 17 May 2024 | 16,453 | 4,322,557 | - | 3.3 | 54,652 | Common Stock |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2024 | 1,526 | 0 | - | - | Restricted Stock Unit | |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2024 | 1,526 | 4,339,010 | - | - | Common Stock | |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 17,057 | 17,057 | - | - | Restricted Stock Unit | |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Apr 2024 | 16,883 | 4,337,484 | - | - | Common Stock | |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Apr 2024 | 16,883 | 0 | - | - | Restricted Stock Unit | |
| Herbalife Nutrition Ltd | Michael O. Johnson | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 982,800 | 982,800 | - | - | Stock Appreciation Rights | |
| Herbalife Nutrition Ltd | Johnson Michael O. | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 495,662 | 1,099,369 (0%) | 0% | 0 | Common Stock | |
| Herbalife Nutrition Ltd | O. Michael Johnson | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 84,839 | 1,184,208 (0%) | 0% | 0 | Common Stock | |
| Herbalife Nutrition Ltd | Johnson O. Michael | Director, Chairman & CEO | Purchase of securities on an exchange or from another person at price $ 8.07 per share. | 16 Feb 2024 | 61,725 | 603,707 (0%) | 0% | 8.1 | 498,300 | Common Stock |
| Herbalife Nutrition Ltd | Johnson Michael O. | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.07 per share. | 16 Feb 2024 | 30,351 | 1,153,857 (0%) | 0% | 8.1 | 244,933 | Common Stock |
| Idexx Laboratories | Perkins Johnson Michael | EVP and CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 3,132 | 3,132 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| Idexx Laboratories | Perkins Johnson Michael | EVP and CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 714 | 714 | - | - | Restricted Stock Unit | |
| Idexx Laboratories | Perkins Johnson Michael | EVP and CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 178 | 178 | - | - | Incentive Stock Option (right-to-buy) | |
| Idexx Laboratories | Perkins Michael Johnson | EVP and CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 176 | 243 (0%) | 0% | 0 | Common Stock | |
| Idexx Laboratories | Johnson Perkins Michael | EVP and CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 176 | 528 | - | - | Restricted Stock Unit | |
| Idexx Laboratories | Johnson Michael Perkins | EVP and CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 560.57 per share. | 14 Feb 2024 | 60 | 183 (0%) | 0% | 560.6 | 33,634 | Common Stock |
| Herbalife Nutrition Ltd | Johnson Michael O. | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.07 per share. | 22 Dec 2023 | 79,100 | 541,982 (0%) | 0% | 15.1 | 1,192,037 | Common Stock |
| Zentalis Pharma Inc | David Michael Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 19,059 | 127,389 | - | 0 | Common Stock | |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.08 per share. | 08 Jun 2023 | 6,440 | 4,402,620 | - | 4.1 | 26,262 | Common Stock |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.15 per share. | 08 Jun 2023 | 5,000 | 4,394,060 | - | 4.2 | 20,750 | Common Stock |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.14 per share. | 08 Jun 2023 | 3,560 | 4,399,060 | - | 4.1 | 14,741 | Common Stock |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 17,793 | 4,407,534 | - | - | Common Stock | |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 17,793 | 0 | - | - | Restricted Stock Units | |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 1,526 | 1,526 | - | - | Restricted Stock Unit | |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 1,526 | 4,409,060 | - | - | Common Stock | |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2023 | 16,883 | 16,883 | - | - | Restricted Stock Unit | |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.47 per share. | 07 Mar 2023 | 155 | 4,389,741 | - | 6.5 | 1,003 | Common Stock |
| Enviva Inc | Michael A. Johnson | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 2,361 | 2,361 (0%) | 0% | 0 | Common Stock | |
| Enviva Inc | Michael A. Johnson | VP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.27 per share. | 06 Mar 2023 | 904 | 1,457 (0%) | 0% | 39.3 | 35,500 | Common Stock |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.62 per share. | 02 Mar 2023 | 22,000 | 4,389,896 | - | 6.6 | 145,567 | Common Stock |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.53 per share. | 02 Mar 2023 | 7,700 | 4,411,896 | - | 6.5 | 50,283 | Common Stock |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.72 per share. | 28 Feb 2023 | 28,200 | 4,429,096 | - | 6.7 | 189,366 | Common Stock |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.58 per share. | 28 Feb 2023 | 9,500 | 4,419,596 | - | 6.6 | 62,528 | Common Stock |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.69 per share. | 24 Feb 2023 | 8,974 | 4,457,296 | - | 6.7 | 60,008 | Common Stock |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.63 per share. | 24 Feb 2023 | 1,101 | 4,466,270 | - | 6.6 | 7,303 | Common Stock |
| Idexx Laboratories | Michael Perkins Johnson | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 4,346 | 4,346 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| Idexx Laboratories | Michael Perkins Johnson | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 804 | 804 | - | - | Incentive Stock Option (right-to-buy) | |
| Idexx Laboratories | Michael Perkins Johnson | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 704 | 4,086 | - | - | Restricted Stock Unit | |
| Enviva Inc | Michael A. Johnson | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 3,397 | 3,397 | - | - | Restricted Stock Units | |
| Enviva Inc | Michael A. Johnson | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 3,004 | 3,004 | - | - | Restricted Stock Units | |
| Herbalife Nutrition Ltd | Michael O. Johnson | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2022 | 783,699 | 783,699 | - | - | Stock Appreciation Rights | |
| Herbalife Nutrition Ltd | Michael O. Johnson | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2022 | 346,020 | 621,082 (0%) | 0% | 0 | Common Stock | |
| Herbalife Nutrition Ltd | Michael O. Johnson | Director, Chairman & interim CEO | Purchase of securities on an exchange or from another person at price $ 12.69 per share. | 09 Dec 2022 | 19,675 | 275,062 (0%) | 0% | 12.7 | 249,646 | Common Stock |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.25 per share. | 14 Jun 2022 | 889 | 4,467,281 | - | 2.3 | 2,004 | Common Stock |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.25 per share. | 13 Jun 2022 | 5,620 | 4,468,170 | - | 2.3 | 12,645 | Common Stock |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.66 per share. | 09 Jun 2022 | 9,120 | 4,478,360 | - | 2.7 | 24,252 | Common Stock |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.54 per share. | 09 Jun 2022 | 4,570 | 4,473,790 | - | 2.5 | 11,630 | Common Stock |
| Zentalis Pharma Inc | David Michael Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 24,871 | 108,330 | - | 0 | Common Stock | |
| Idexx Laboratories | Michael Perkins Johnson | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 3,382 | 3,382 | - | - | Restricted Stock Unit | |
| Herbalife Nutrition Ltd | Michael O. Johnson | Director | Purchase of securities on an exchange or from another person at price $ 22.85 per share. | 12 May 2022 | 5,840 | 255,387 (0%) | 0% | 22.9 | 133,444 | Common Stock |
| Herbalife Nutrition Ltd | Michael O. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 5,387 | 249,547 (0%) | 0% | 0 | Common Stock | |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 17,793 | 17,793 | - | - | Restricted Stock Units | |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 1,526 | 4,487,480 | - | - | Common Stock | |
| Flux Power Holdings inc | Michael Johnson | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 1,526 | 3,052 | - | - | Restricted Stock Units | |
| Enviva Inc | Michael A. Johnson | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 1,608 | 1,608 | - | - | Restricted Stock Units | |
| Enviva Inc | Michael A. Johnson | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2021 | 7,358 | 7,358 | - | - | Phantom Units | |
| Zentalis Pharma Inc | David Michael Johnson | Director | Sale of securities on an exchange or to another person at price $ 66.58 per share. | 04 Oct 2021 | 7,904 | 81,059 | - | 66.6 | 526,240 | Common Stock |
| Zentalis Pharma Inc | David Michael Johnson | Director | Sale of securities on an exchange or to another person at price $ 65.95 per share. | 04 Oct 2021 | 4,892 | 88,963 | - | 66.0 | 322,628 | Common Stock |